TG Therapeutics Inc (TGTX)
16.31
-0.58
(-3.43%)
USD |
NASDAQ |
May 31, 16:00
16.29
-0.02
(-0.12%)
After-Hours: 20:00
TG Therapeutics Accounts Payable (Quarterly)
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
September 30, 2020 | 34.66M |
June 30, 2020 | 29.67M |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | 40.20M |
December 31, 2018 | |
September 30, 2018 | 37.92M |
June 30, 2018 | 35.39M |
March 31, 2018 | 32.51M |
December 31, 2017 | |
September 30, 2017 | 18.18M |
June 30, 2017 | |
March 31, 2017 | 18.92M |
December 31, 2016 | 15.27M |
September 30, 2016 | 15.55M |
June 30, 2016 | 13.08M |
March 31, 2016 | 8.139M |
December 31, 2015 | 9.346M |
September 30, 2015 | 8.583M |
June 30, 2015 | 8.254M |
March 31, 2015 | 8.880M |
December 31, 2014 | 3.992M |
September 30, 2014 | 7.968M |
Date | Value |
---|---|
June 30, 2014 | 1.899M |
March 31, 2014 | 1.639M |
December 31, 2013 | 4.764M |
September 30, 2013 | 4.325M |
June 30, 2013 | 2.248M |
March 31, 2013 | 1.388M |
December 31, 2012 | 1.117M |
September 30, 2012 | 1.799M |
June 30, 2012 | 0.3217M |
March 31, 2012 | 0.4675M |
December 31, 2011 | 0.6666M |
September 30, 2011 | 0.1677M |
June 30, 2011 | 0.2076M |
March 31, 2011 | 0.1833M |
December 31, 2010 | 0.2235M |
September 30, 2010 | 0.3958M |
June 30, 2010 | 0.3738M |
March 31, 2010 | 0.3027M |
December 31, 2009 | 0.2912M |
September 30, 2009 | 0.1431M |
June 30, 2009 | 0.1729M |
March 31, 2009 | 0.1445M |
December 31, 2008 | 0.5423M |
September 30, 2008 | 0.7053M |
June 30, 2008 | 0.6173M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
29.67M
Minimum
Jun 2020
34.66M
Maximum
Sep 2020
32.16M
Average
32.16M
Median
Accounts Payable (Quarterly) Benchmarks
Amicus Therapeutics Inc | 9.21M |
Alnylam Pharmaceuticals Inc | 78.15M |
Cytokinetics Inc | 12.97M |
Insmed Inc | 44.02M |
Madrigal Pharmaceuticals Inc | 21.53M |